Sign Up to like & get
recommendations!
0
Published in 2025 at "Journal of Medicinal Chemistry"
DOI: 10.1021/acs.jmedchem.4c02767
Abstract: A current global limitation to the timely and equitable patient access to PSMA-based therapies for prostate cancer (PCa) is the insufficient PET capacity for pretreatment imaging. However, the extensive global availability of SPECT cameras renders…
read more here.
Keywords:
prostate cancer;
spect imaging;
psma;
radioligands spect ... See more keywords